Fluorescent Imaging Market Growth Projected to Reach US$ 1,290.81 Million by 2030: Growth Plus Reports Study

Newark, New Castle - 19702, USA, April 10, 2023 (GLOBE NEWSWIRE) -- The global fluorescent imaging market is expected to reach US$ 1,290.81 million by 2030, with a revenue CAGR of 6.85%, according to a new Growth Plus Reports research. The research looks at key tactics, trends and potential, competition, evolving industry dynamics, market size, statistics and projections, and key investment territories.

Key Takeaways:

• The increasing use of fluorescent imaging in research and development will drive market revenue growth.
• The non-invasive nature of fluorescent imaging will drive demand for fluorescent imaging.
• North America dominates the global fluorescent imaging market. 

Request a Free Sample PDF:  https://www.growthplusreports.com/inquiry/request-sample/fluorescent-imaging-market/8499

                                         Fluorescent Imaging Market Scope

Market Drivers
The growing use of fluorescent imaging in research and development will drive the revenue growth of fluorescent imaging market. Furthermore, the launch of new and innovative fluorescent imaging systems are expected to boost the market revenue growth rate. Apart from this, its excellent sensitivity and precision for non-invasive detection of cancerous tissues is expected to support the market's revenue growth.

Market Segmentation
Growth Plus Reports has analyzed global fluorescent imaging market from four perspectives: Type, Technology, Component, End User, and Region.

Type Segmentation: Based on the type, the global fluorescent imaging market is segmented into inverted fluorescence microscopy and upright fluorescence microscopy. The upright fluorescence microscopy segment dominates the market with the largest revenue share because when compared to inverted fluorescence imaging, upright fluorescent imaging has several benefits, including the ability to photograph bigger materials and the potential of better resolution due to less light scattering.

Technology Segmentation: Based on the technology, the global fluorescent imaging market is segmented into wide-field imaging, total internal reflection fluorescence imaging, and confocal imaging. The wide-field imaging segment dominates the market because it is a quick and simple method with a benefit in single-cell layer imaging.

Component Segmentation: Based on the component, the global fluorescent imaging market is segmented into equipment and software consumables. The equipment segment dominates the market because it provides numerous benefits, including high sensitivity, specificity, and resolution, and the ability to visualise biological processes in real time.

End-User Segmentation: Based on the end-user, the global fluorescent imaging market is segmented into research laboratories, hospitals, diagnostics centers, and others. The research laboratories segment dominates the market because fluorescent imaging is an effective tool used in research labs to visualise and study biological processes at the cellular and molecular levels.

Regional Growth Dynamics
Based on the region, the global fluorescent imaging market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. 

North America dominates the global fluorescent imaging market with the largest revenue share of the market. are the major factors responsible for North America's significant revenue share in the global market.  

Request For Customization – https://www.growthplusreports.com/inquiry/customization/fluorescent-imaging-market/8499

Competitive Landscape

Some key players operating in the global fluorescent imaging market are:

• Amscope 
• Anmo Electronics Corp.
• Bruker Corp.
• Cairn Research Ltd. 
• Chongqing Coic Industrial Co. Ltd.
• Delmic B.V.
• Doric Lenses Inc.
• Edmund Optics Inc.
• Etaluma Inc.
• Euromex Microscopen BV

The fluorescent imaging market is somewhat competitive with a number of global corporations. Leading players invest in technological advancements, research and development, and mergers and acquisitions to strengthen their market position.

Recent developments:

• Axion BioSystems, a life sciences instruments company based in the United States that specializes in complex live-cell assay systems, acquired CytoSMART Technologies in 2022. Both companies expect substantial advantages from accelerating joint expansion.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL FLUORESCENT IMAGING MARKET - ANALYSIS & FORECAST, BY TYPE
   1. Inverted Fluorescence Imaging 
   2. Upright Fluorescence Imaging                                 
6. GLOBAL FLUORESCENT IMAGING MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY
   1. Wide-Field Imaging
   2. Total Internal Reflection Fluorescence (TIRF) Imaging
   3. Confocal Imaging
7. GLOBAL FLUORESCENT IMAGING MARKET - ANALYSIS & FORECAST, BY COMPONENT
   1. Equipment 
   2. Software & Consumables 
8. GLOBAL FLUORESCENT IMAGING MARKET - ANALYSIS & FORECAST, BY END USER 
   1. Research Laboratories
   2. Hospitals
   3. Diagnostics Centers
   4. Others

FLUORESCENT IMAGING MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8499

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse Latest Healthcare Related Reports:

Mycology Immunoassays Testing Market by Technology (ELISA, Rapid Tests, ELISPOT, Polymerase Chain Reaction (PCR)), End Users (Hospitals, Clinical Laboratories, Blood Banks, Research Centers, Others) - Global Outlook and Forecast 2023-2031

Meningococcal Meningitis Treatment Market by Treatment Type (Antibiotic Therapy, Vaccine), Route of Administration (Injectable, Oral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies)- Global Outlook and Forecast 2023-2031

IVUS Catheters Market by Modality (Virtual Histology IVUS, iMap IVUS), Type (Mechanical IVUS Catheters, Digital IVUS Catheters), Indication (Aortic Aneurysm, Coronary Artery Disease), End User (Hospitals, Ambulatory Surgical Centers) - Global Outlook and Forecast 2023-2031

Cardiac Diagnostic Catheters Market by Type (Electrophysiology Catheters, PTCA Balloons Catheters), End User (Hospitals, Diagnostics and Imaging Centers) - Global Outlook and Forecast 2023-2031

Bioprocess Containers Market by Type (2D Bioprocess Containers, 3D Bioprocess Containers), Application (Upstream Process, Downstream Process), End User (Pharmaceutical & Biopharmaceutical Companies) - Global Outlook and Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.